Reich, Kristian, Mark Lebwohl, Carle Paul, Mads Ropke, Monika Rosen, and Klaus Hansen. “Brodalumab, a Human Anti-Interleukin-17 Receptor A Monoclonal Antibody, Shows Low Immunogenicity in Patients With Moderate-to-Severe Psoriasis”. SKIN The Journal of Cutaneous Medicine 2, no. S1 (February 23, 2018): S1. Accessed January 10, 2025. https://skin.dermsquared.com/skin/article/view/254.